Sleep and Emotion Processing in Adolescent Post-traumatic Stress Disorder
Key facts
- Who runs it
- University of Wisconsin, Madison
- Where
- Madison, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 180 people, planned
- Started
- 16 Jul 2024
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- SmartSleep device
- Record updated
- 15 July 2026
Who can take part
- Age
- 14 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 31 criteriaShow less
Who can take part
- All participants must meet all of the following criteria:
- Aged 14-18 years old, inclusive
- Must agree to inform the investigators within 48 hours of any emergent medical conditions and procedures
- Able to lie still on their back for up to 1 hour
- Must not be pregnant
- Must agree not to participate in any other interventional clinical trials during the duration of the study
- Must be willing to comply with all study procedures
- Agree to have study visits video and/or audio recorded, including consent visit, clinical assessments (for staff training) and in-laboratory sleep visits (recording deleted within one month of study visit)
- A primary parent or guardian is willing participate in the study and to provide informed consent
- Are fluent in or predominantly speaking and reading in English; In addition, PTSD and TEC youth must satisfy the following criteria:
- Must have a history of at least one traumatic event of any type, as defined by the DSM-V. This may include exposure to physical or sexual abuse, witnessing violence against loved ones or friends, traumatic accidents, natural disasters, death of a close family member etc; Additional criteria for PTSD youth:
- At baseline, meet threshold for DSM-5 criteria for current severe PTSD, as determined by the semi-structured clinical interview (KSADS)
Who cannot take part
- Participation in the last 30 days in a clinical study involving an investigational drug
- Current use of medications or other drugs (i.e., alcohol) in a manner that may interfere with sleep
- No history of or current psychopathology, as defined in the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS), with exception of past specific phobia and past, resolved episodes of depressive or anxiety disorders. Provided that:; The episode is not current (i.e. does not meet current criteria as assessed by the KSADS),; The participant is not currently receiving psychiatric treatment (medication or psychotherapy) for mood/anxiety, and; There is no current serious suicide risk (per KSADS/C-SSRS)
- Any participant presenting current serious suicide risk, as determined through the KSADS, responses to C-SSRS, and/or clinical judgment of the investigator, will be excluded; however, history of suicide attempts is not an exclusion. Would present a serious risk to others as established through clinical interview and contact with treating physician
- Neurodevelopmental disorders such as autism spectrum disorder
- Currently impaired by any medical condition that would prevent study participation
- Neurological disorder(s) such as seizures, epilepsy, or brain tumors (Tourette's disorder, as diagnosed in the KSADS, is not exclusionary for TEC/PTSD youth)
- Current diagnosis of a sleep disorder (self-report)
- Any history of any traumatic experience as defined by the DSM-V, including IPV exposure, neglect, or emotional abuse etc; PTSD Youth:
- Current diagnosis of or history of psychotic disorder, bipolar disorder, or autism spectrum disorder diagnosed by the KSADS interview. No other co-morbid disorders are exclusionary; TEC Youth:
- A current diagnosis of PTSD or a current diagnosis of or history of psychotic disorder, bipolar disorder, or autism spectrum disorder diagnosed by the KSADS interview
- Caregiver or adolescent is unwilling or unable to give adequate informed consent
- Are likely, in the investigator's opinion and via observation during the screening and clinical assessment period, to be re-exposed to their index trauma or other significant trauma, lack social support, or lack a stable living situation during study participation
- Any finding(s), based on the screening process, that the PI feels would make the study unsuitable for the participant
- MRI contraindication
- Claustrophobia or inability lie still in the scanner after practice MRI sessions
- Intellectual Disability (IQ less than 70, per self-report)
- Traumatic brain injury with ongoing symptoms, including headache, visual disturbances, and/or impairments in concentration
- Possible pregnancy; Exclusions for Typically developing youth:
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 14 and 18 years old?
This trial is currently available in United States.
- University of WisconsinMadison, United StatesContact: Sara Heyn, JD, PhDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to characterize the role of sleep, emotion processing, and daily affect in post-traumatic stress disorder (PTSD) and whether improving sleep quality using slow wave activity enhancement will impact next-day affect in youth.
Read full original descriptionShow less
Participants will attend 4 study visits:
* A clinical and trauma assessment visit * A testing day that may include cognitive testing, surveys, and an MRI. * An overnight sleep study following one week of at-home sleep recordings with the device in the sham condition * An overnight sleep study following one week of at-home sleep recordings with the device in the sleep enhancement condition
The 2 groups in the trial
- Stimulation mode firstTreatment being tested
During one week, the SmartSleep device will be set to stimulation mode.
Treatment: SmartSleep device
- Sham mode firstSham treatment, for comparison
During one week, the SmartSleep device will be set to sham.
Treatment: SmartSleep device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sleep and Emotion Processing in Adolescent Post-Traumatic Stress Disorder
- Criteria questions
- Built from NCT06341413, who can take part
- Record updated
- 15 July 2026